Clinical Trial: Fecal Resistance Gene-Guided Individualized Dual Therapy in Treatment-Naive Patients With Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial (China)

Posted On: 2026-10-21

China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Fecal Resistance Gene-Guided Individualized Dual Therapy in Treatment-Naive Patients With Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134773

Registration Time: 2026/10/20

Type: Interventional study

Primary Sponsor: Peking University First Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347250

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Fecal Resistance Gene-Guided Individualized Dual Therapy in Treatment-Naive Patients With Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial (China)